Rohto Pharmaceutical Co.,Ltd. provided consolidated earnings guidance for the fiscal year ending March 31, 2024. For the year, the company expected net sales of JPY 263,000 million, Operating profit of JPY 37,000 million, Profit attributable to owners of parent of JPY 27,500 million and Basic earnings per share of JPY 120.54.